stars 1 stars 2 stars 3

OmniaBio is redefining the future of cell therapy manufacturing through its proprietary AI-powered Intelligent Factory™. Purpose-built to accelerate discoveries and industrialize production, the Intelligent Factory™ integrates artificial intelligence and automation across the entire manufacturing lifecycle. With a focus on autologous CAR-T and other advanced therapies, OmniaBio’s platform enables scalable, efficient, and high-fidelity production by embedding predictive analytics, robotic bioprocessing, and digital quality systems into a unified, closed-loop system. This approach not only enhances throughput and consistency but also positions OmniaBio as a next-generation CDMO partner for innovators seeking to bring life-saving therapies to patients faster.

OmniaBio Questions

The OmniaBio annual revenue was $63.4 million in 2026.

Jason Cervi is the CFO of OmniaBio.

146 people are employed at OmniaBio.

OmniaBio is based in Hamilton, Ontario.

Top OmniaBio Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users